Caption Management’s BioNTech BNTX Stock Holding History

Caption Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Buy	11,946 +7,446	+165%	+$701K	0.01%	1099
2026 Q1	$400K	Sell	4,500 -2,500	-36%	-$257K	﹤0.01%	1249
2025 Q4	$666K	Buy	+7,000	New	+$705K	﹤0.01%	1180
2023 Q4	–	Sell	-9,900	Closed	-$1.08M	–	1358
2023 Q3	$1.08M	Buy	+9,900	New	+$1.09M	0.02%	754
2022 Q1	–	Sell	-2,200	Closed	-$568K	–	1475
2021 Q4	$568K	Buy	2,200 +2,000	+1,000%	+$548K	0.01%	1219
2021 Q3	$55K	Buy	+200	New	+$63.6K	﹤0.01%	1434
2020 Q3	–	Sell	-16,800	Closed	-$1.21M	–	1039
2020 Q2	$1.12M	Buy	+16,800	New	+$839K	0.04%	509

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Caption Management's BNTX Position: Q2 2026 in Review

Caption Management increased its BioNTech (BNTX) stake by 165% in Q2 2026, buying an estimated $701K and bringing the position to 11,946 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #1099.

Caption Management first reported a position in BNTX in Q2 2020 and has held it in 7 quarters since. The position peaked at $1.12M in Q2 2020. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Caption Management held 11,946 shares of BioNTech worth $1.11M as of Q2 2026.
Caption Management bought 7,446 BioNTech shares in Q2 2026, an estimated $701K.
BioNTech made up 0.01% of Caption Management's portfolio in Q2 2026, its #1099 holding.
Caption Management first reported a position in BioNTech in Q2 2020 and has held it in 7 quarters since.
Caption Management's BioNTech position peaked at $1.12M in Q2 2020.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.